Writer Amy Wallen took on a 60-mile Susan G. Komen challenge as a way to test her stamina while doing something positive for friends.
Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback